secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK:        0001133869
Form:       8-K
Filed at:   2023-06-13T23:59:59+00:00
Accession:  0001558370-23-011050
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Capricor Therapeutics amends charter to extend officer exculpation under DGCL
-----------------------------------------------------------------------------

- Stockholders approved the amendment on June 12, 2023.
- Certificate of Amendment filed with Delaware Secretary of State on June 13, 2023, effective same day.
- Amendment extends exculpation of monetary liability to officers for breach of fiduciary duty, as permitted by DGCL Section 102(b)(7).
- Previously only directors were exculpated; change aligns with Delaware law update effective August 1, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133869/000155837023011050/0001558370-23-011050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133869/000155837023011050/capr-20230612x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer